PAVmed (PAVM) Enterprise Value Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -118.65% |
| Jun 30, 2025 | -145.88% |
| Mar 31, 2025 | -139.97% |
| Dec 31, 2024 | -159.19% |
| Jun 30, 2024 | 559.87% |
| Mar 31, 2024 | 238.07% |
| Dec 31, 2023 | 153.19% |
| Sep 30, 2023 | 102.75% |
| Jun 30, 2023 | 85.83% |
| Mar 31, 2023 | 64.26% |
| Dec 31, 2022 | 67.85% |
| Sep 30, 2022 | -0.54% |
| Jun 30, 2022 | -3.64% |
| Mar 31, 2022 | 9.56% |
| Dec 31, 2021 | -203.22% |
| Sep 30, 2021 | -264.09% |
| Jun 30, 2021 | -415.13% |
| Mar 31, 2021 | -409.81% |
| Dec 31, 2020 | -179.04% |
| Sep 30, 2020 | -119.93% |
| Jun 30, 2020 | -18.12% |
| Mar 31, 2020 | -125.60% |
| Dec 31, 2019 | 16.11% |
| Sep 30, 2019 | 50.52% |
| Jun 30, 2019 | 35.32% |
| Mar 31, 2019 | -21.64% |
| Dec 31, 2018 | -446.12% |
| Sep 30, 2018 | -199.93% |
| Jun 30, 2018 | -13,561.70% |
| Mar 31, 2018 | -300.89% |
| Dec 31, 2017 | -162.09% |
| Sep 30, 2017 | -73.96% |
| Jun 30, 2017 | 97.29% |
| Mar 31, 2017 | -283.67% |
| Dec 31, 2016 | 23.67% |
| Sep 30, 2016 | -26.38% |
| Jun 30, 2016 | -479.56% |